1.745USD+5.12%Mkt Cap: 27.68M USDP/E: —Last update: 2026-06-01
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap27.68M USD
Enterprise Value7.99M USD
Revenue (TTM)320.00K USD
Gross Profit320.00K USD
Net Income (TTM)-11.23M USD
Revenue/Share0.0220 USD
Last Price1.745 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.69
PEG—
EV/EBITDA-0.63
EV/Revenue24.96
P/S81.54
P/B3.18
EPS (TTM)-0.70
EPS (Forward)-0.97
52W Range
0.769062% of range2.350
52W High2.350 USD
52W Low0.7690 USD
Profitability
Gross Margin100.00%
Oper. Margin-911.88%
EBITDA Margin0.00%
Profit Margin-3509.69%
ROE-114.28%
ROA-61.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.82M USD
CapEx (TTM)8.00K USD
FCF Margin-3191.80%
FCF Yield-36.89%
Net Debt-13.37M USD
Net Debt/EBITDA1.06
Balance Sheet
Debt/Equity0.14
Current Ratio2.13
Quick Ratio1.86
Book Value/Sh0.5160 USD
Cash/Share0.9340 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateSep 11, 2024
Analyst Consensus
Rating—
Target (Mean)9.750 USD
Target Range9.750 USD – 9.750 USD
# Analysts1
Ownership
Shares Out.15.91M
Float15.74M
Insiders4.85%
Institutions6.15%
Short Interest
Short Ratio2.2d
Short % Float1.78%
Short % Out.1.77%
Shares Short274.06K
Short (prev mo.)353.88K
Technical
SMA 501.331 (+31.1%)
SMA 2001.267 (+37.7%)
Beta0.38
S&P 52W Chg27.94%
Avg Vol (30d)240.06K
Avg Vol (10d)287.21K
Technical Indicators
RSI (14)57.9
MACD0.0983
MACD Signal0.0888
MACD Hist.+0.0094
BB Upper1.826 USD
BB Middle1.533 USD
BB Lower1.241 USD
BB Width38.12%
ATR (14)0.1471 USD
Vol Ratio (20d)0.67x